Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Antigenic variation is a key mechanism by which pathogens evade the immune system. New research has shown how trypanosomes ...

In a study published today in the ExRNA journal, researchers from the Novosibirsk Institute of Chemical Biology and Fundamental Medicine have proved that pre-analytical variables, as blood plasma or ...

Researchers in Japan successfully used a nonviral system to introduce a transgene – that is, a gene that has been ...

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to ...

Predictive biomarkers of immunotherapy response are critical for clinical practice. In this study, baseline plasma sCD27 was ...

First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ImmutepGlobal Phase III with ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...